DUBAI, United Arab Emirates, The approximately US$ 30.04 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.7% CAGR during 2022-2028, according to a recent research report of Future Market Insights.
Search jobs 06-May-2021 Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market with Covid-19 Pandemic Analysis, Growth Rate, New Trend Analysis Forecast by 2028 | Pfizer, Inc., Valeant Pharmaceuticals Inc., Novartis AG, Bayer AG & so on…
The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of
Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.
The World Population Prospects’ data (2017) projected that the number of individuals aged 60 years and above will double by 2050, and triple by 2100. With such a high pace estimated for the growth of population aged 60 years and above, it is more likely that the prevalence of aging related health conditions will also increase at a consider